107 related articles for article (PubMed ID: 1062220)
1. Cytotoxic effects on splenic ultrafiltrates upon leukaemic lymphocytes.
Attallah AM; Houck JC
Br J Cancer; 1975 Dec; 32(6):693-9. PubMed ID: 1062220
[TBL] [Abstract][Full Text] [Related]
2. In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.
Khare AG; Advani SH; Gangal SG
Br J Cancer; 1981 Jan; 43(1):13-8. PubMed ID: 6450603
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and cell killing in dividing and nondividing leukemic cells in vitro and in vivo by natural splenic cytotoxic factor.
Attallah AM; Malinin GI; Houck JC; Johnson JB; Petricciani JC
Int Arch Allergy Appl Immunol; 1979; 60(4):361-70. PubMed ID: 500228
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of rabbit anti-mouse brain serum on theta bearing lymphocytes of AKR mice.
Filppi JA; Rheins MS; Pierre RL
Immunology; 1975 Apr; 28(4):659-68. PubMed ID: 1097331
[TBL] [Abstract][Full Text] [Related]
5. The response of C3H mice to an L1210 tumor allograft.
Nevalainen DE
Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):771-4. PubMed ID: 4828768
[No Abstract] [Full Text] [Related]
6. The in vitro role of thymus-dependent cells in DNA synthesis and LT secretion by PHA-stimulated mouse lymphoid cells.
Shacks SJ; Chiller J; Granger GA
Transplant Proc; 1972 Sep; 4(3):303-5. PubMed ID: 5080602
[No Abstract] [Full Text] [Related]
7. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.
Levy R; Dilley J; Fox RI; Warnke R
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6552-6. PubMed ID: 316541
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts.
Rodey GE; Sprader JC; Bortin MM
Cancer Res; 1974 Jun; 34(6):1289-94. PubMed ID: 4275007
[No Abstract] [Full Text] [Related]
9. Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes.
Namba Y; Jegasothy BV; Waksman BH
J Immunol; 1977 Apr; 118(4):1379-84. PubMed ID: 300407
[TBL] [Abstract][Full Text] [Related]
10. The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells.
Yutoku M; Grossberg AL; Pressman D
J Immunol; 1975 Jul; 115(1):69-74. PubMed ID: 1097506
[TBL] [Abstract][Full Text] [Related]
11. Nature of the stimulating cell in the syngeneic and the allogeneic mixed lymphocyte reaction in mice.
Von Boehmer H; Shortman K; Adams P
J Exp Med; 1972 Dec; 136(6):1648-60. PubMed ID: 4539312
[TBL] [Abstract][Full Text] [Related]
12. Cytostasis of mouse and human monolayer cell cultures by normal, unstimulated lymphocytes.
Jamieson CW; Wallace JH
J Immunol; 1970 Jul; 105(1):7-13. PubMed ID: 5425355
[No Abstract] [Full Text] [Related]
13. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
Fuji H; Mihich E
Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
[TBL] [Abstract][Full Text] [Related]
14. Measurement of the number of bone marrow multipotential stem cells in AKR leukaemic mice.
Frindel E; Chevalier C
Biomedicine; 1975 Jun; 23(5):166-7. PubMed ID: 1081411
[TBL] [Abstract][Full Text] [Related]
15. Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.
Han T; Minowada J
Immunology; 1978 Aug; 35(2):333-9. PubMed ID: 155647
[TBL] [Abstract][Full Text] [Related]
16. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
17. Further purification and chemical characterization of the lymphocyte-inhibiting-factor extracted from thymus (LIFT).
Kiger N; Florentin I; Lorans G; Mathe G
Immunology; 1977 Oct; 33(4):439-48. PubMed ID: 924515
[TBL] [Abstract][Full Text] [Related]
18. Mixed culture of human foetal and adult cells.
Pegrum GD
Immunology; 1971 Jul; 21(1):159-64. PubMed ID: 5558031
[TBL] [Abstract][Full Text] [Related]
19. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.
Lai A Fat RF; van Furth R
Immunology; 1975 Feb; 28(2):359-68. PubMed ID: 804438
[TBL] [Abstract][Full Text] [Related]
20. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
Han T; Gomez GA; Minowada J
Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
